Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 02-2017 | 11-2016 | 08-2016 | 05-2016 | 02-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,796 | 8,811 | 4,444 | 9,642 | 10,202 |
| TOTAL | $12,734 | $13,564 | $7,090 | $11,494 | $12,215 |
| Non-Current Assets | |||||
| PPE Net | 19 | 18 | 23 | 25 | 16 |
| Intangibles | 2,005 | 2,092 | 2,180 | 2,267 | 2,355 |
| TOTAL | $2,024 | $2,110 | $2,203 | $2,292 | $2,371 |
| Total Assets | $14,758 | $15,674 | $9,293 | $13,786 | $14,586 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,234 | 5,903 | 2,915 | 2,468 | 2,389 |
| Accrued Expenses | 125 | 439 | 125 | 1,113 | 991 |
| TOTAL | $5,358 | $6,341 | $3,039 | $3,581 | $3,379 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,982 | 3,956 | 0 | 0 | 0 |
| TOTAL | $3,982 | $3,956 | $N/A | $N/A | $N/A |
| Total Liabilities | $9,341 | $10,297 | $3,039 | $3,581 | $3,379 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,468 | 142,222 | 138,222 | 124,534 | 118,372 |
| Common Shares | 150 | 138 | 125 | 123 | 118 |
| Retained earnings | -116,160 | -108,048 | -102,580 | -97,226 | -90,729 |
| TOTAL | $5,417 | $5,377 | $6,253 | $10,206 | $11,206 |
| Total Liabilities And Equity | $14,758 | $15,674 | $9,293 | $13,786 | $14,586 |